![](/images/graphics-bg.png)
Present and Future : Pharmacologic Treatment of Obesity
Joint Authors
Source
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-13, 13 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-02-08
Country of Publication
Egypt
No. of Pages
13
Main Subjects
Abstract EN
Obesity now presents one of the biggest health problems of our times.
Diet and exercise are best for both prevention and treatment; unfortunately, both require much discipline and are difficult to maintain.
Medications offer a possible adjunct, but their effect is modest, they are limited by side effects, and the weight loss lasts only as long as the drug is being taken, since as soon as treatment is stopped, the weight is regained.
Sibutramine, a sympathomimetic medication which was available for long-term treatment, is the most recent of the drugs to be withdrawn from the market due to side effects; in this case it was an increased risk of cardiovascular events.
This paper reviews those medications which are available for treatment of obesity, including many of those recently taken off the market.
It also discusses some of the newer treatments that are currently being investigated.
American Psychological Association (APA)
Glandt, Mariela& Raz, Itamar. 2011. Present and Future : Pharmacologic Treatment of Obesity. Journal of Obesity،Vol. 2011, no. 2011, pp.1-13.
https://search.emarefa.net/detail/BIM-487028
Modern Language Association (MLA)
Glandt, Mariela& Raz, Itamar. Present and Future : Pharmacologic Treatment of Obesity. Journal of Obesity No. 2011 (2011), pp.1-13.
https://search.emarefa.net/detail/BIM-487028
American Medical Association (AMA)
Glandt, Mariela& Raz, Itamar. Present and Future : Pharmacologic Treatment of Obesity. Journal of Obesity. 2011. Vol. 2011, no. 2011, pp.1-13.
https://search.emarefa.net/detail/BIM-487028
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-487028